Last reviewed · How we verify

NCT06240819

Cross Body vs Sleeper Stretch on Pain, Range of Motion and Functional Performance in Cricket Bowlers.

Status unknown NA Last updated 5 February 2024
What this trial tests

NA trial testing Sleeper Stretch in Pain in 22 participants. Status unknown.

Timeline
20 October 2023
Primary endpoint
20 February 2024
20 February 2024

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment22
Start date20 October 2023
Primary completion20 February 2024
Estimated completion20 February 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 20 to 30, any sex, with Pain or Range of Motion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is randomized and single-blinded. Ethical approval is taken from ethical committee of Riphah International University, Lahore. Participants who meet the inclusion criteria will be enrolled and allocated in group A \& B through sealed envelope method by Non-probability Convenient random sampling technique. Subjects in Group A will receive sleeper stretch in a side lying position. Group B will receive cross-body stretch will be done in sitting position

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sleeper Stretch

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06240819.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing